Nab-paclitaxel Based Regimens VS Paclitaxel Based Regimens in Neoadjuvant Treatment for TNBC

NCT04067102 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped No patients recruited

Conditions

Triple Negative Breast Cancer

Interventions

DRUG: Albumin bound (nab)-paclitaxel combined with carboplatin followed by epirubicin and cyclophosphamide
DRUG: paclitaxel combined with carboplatin followed by epirubicin and cyclophosphamide

Sponsor

Hebei Medical University Fourth Hospital